We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Flora Growth Corporation | NASDAQ:FLGC | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.28 | 1.28 | 1.29 | 1.39 | 1.23 | 1.25 | 244,546 | 20:22:52 |
FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Flora Growth Corp. [ FLGC ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 11/15/2023 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Shares | 11/15/2023 | A | 74,512 | A | (1) | 84,698(2) | D | |||
Common Shares | 2,021(2) | I | See footnote(3) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
1. Represents grant of restricted shares which vest on January 1, 2024. |
2. Total reflects 20:1 reverse stock split effected by the Issuer on June 7, 2023. |
3. Held by 1317433 B.C. Limited, a company in which the Reporting Person is the sole director and equity owner. The Reporting Person disclaims beneficial ownership of the securities held by 1317433 B.C. Limited except to the extent of his pecuniary interest therein. |
Remarks: |
Exhibit 24.1 Power of Attorney |
/s/ Dany Vaiman as attorney-in-fact for Edward Wood | 11/15/2023 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
1.
|
Sign any and all instruments, certificates and documents appropriate or required to be executed on behalf of
the undersigned with respect to the securities of Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the “Company”) pursuant to sections 13 and 16 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and any and all regulations promulgated thereunder (including, without limitation, any Joint Filing Agreement with respect thereto), and to file the same, with all exhibits thereto, and any other documents in connection
therewith, with the Securities and Exchange Commission (the “SEC”), and with any other entity when and if such is mandated by the Exchange Act or by the Bylaws of the Financial Industry Regulatory Authority;
|
2.
|
prepare, execute, acknowledge, deliver and file a Form ID (including any amendments or authentications
thereto) with respect to obtaining EDGAR codes, with the SEC;
|
3.
|
seek or obtain, as the representative of the undersigned and on behalf of the undersigned, information on
transactions in securities of the Company, from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to such
attorneys-in-fact and the undersigned approves and ratifies any such release of information; and
|
4.
|
perform any and all other acts which in the discretion of such attorneys-in-fact are necessary or desirable
for and on behalf of the undersigned in connection with the foregoing.
|
1.
|
this Power of Attorney authorizes, but does not require, such attorneys-in-fact to act in their discretion on
information provided to such attorneys-in-fact without independent verification of such information;
|
2.
|
any documents prepared and/or executed by such attorneys-in-fact on behalf of any of the undersigned pursuant
to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;
|
3.
|
the attorneys-in-fact do not assume (a) any liability for responsibility to comply with the requirements of
the Exchange Act for any of the undersigned, (b) any liability for any failure to comply with such requirements for any of the undersigned, or (c) any obligation or liability for profit disgorgement under Section 16(b) of the Exchange Act for
any of the undersigned; and
|
4.
|
this Power of Attorney does not relieve any of the undersigned from responsibility for compliance with the
undersigned’s obligations under the Exchange Act, including without limitation the reporting requirements under Sections 13 and 16 of the Exchange Act.
|
1.
|
Sign any and all instruments, certificates and documents appropriate or required to be executed on behalf of
the undersigned with respect to the securities of Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the “Company”) pursuant to sections 13 and 16 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and any and all regulations promulgated thereunder (including, without limitation, any Joint Filing Agreement with respect thereto), and to file the same, with all exhibits thereto, and any other documents in connection
therewith, with the Securities and Exchange Commission (the “SEC”), and with any other entity when and if such is mandated by the Exchange Act or by the Bylaws of the Financial Industry Regulatory Authority;
|
2.
|
prepare, execute, acknowledge, deliver and file a Form ID (including any amendments or authentications
thereto) with respect to obtaining EDGAR codes, with the SEC;
|
3.
|
seek or obtain, as the representative of the undersigned and on behalf of the undersigned, information on
transactions in securities of the Company, from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to such
attorneys-in-fact and the undersigned approves and ratifies any such release of information; and
|
4.
|
perform any and all other acts which in the discretion of such attorneys-in-fact are necessary or desirable
for and on behalf of the undersigned in connection with the foregoing.
|
1.
|
this Power of Attorney authorizes, but does not require, such attorneys-in-fact to act in their discretion on
information provided to such attorneys-in-fact without independent verification of such information;
|
2.
|
any documents prepared and/or executed by such attorneys-in-fact on behalf of any of the undersigned pursuant
to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;
|
3.
|
the attorneys-in-fact do not assume (a) any liability for responsibility to comply with the requirements of
the Exchange Act for any of the undersigned, (b) any liability for any failure to comply with such requirements for any of the undersigned, or (c) any obligation or liability for profit disgorgement under Section 16(b) of the Exchange Act for
any of the undersigned; and
|
4.
|
this Power of Attorney does not relieve any of the undersigned from responsibility for compliance with the
undersigned’s obligations under the Exchange Act, including without limitation the reporting requirements under Sections 13 and 16 of the Exchange Act.
|
1 Year Flora Growth Chart |
1 Month Flora Growth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions